From: PSPHL and breast cancer in African American women: causative gene or population stratification?
AAW | CW | |||||
---|---|---|---|---|---|---|
Del/Del (n = 12) | Del/Ins or Ins/Ins (n = 186) | P-value | Del/Del (n = 343) | Del/Ins or Ins/Ins (n = 220) | P-value | |
Age | 0.475 | 0.596 | ||||
<50 years | 0.33 | 0.44 | 0.27 | 0.29 | ||
≥50 years | 0.67 | 0.56 | 0.73 | 0.71 | ||
Stage | 0.627 | 0.366 | ||||
I | 0.64 | 0.55 | 0.58 | 0.52 | ||
II | 0.36 | 0.32 | 0.30 | 0.32 | ||
III | 0.00 | 0.08 | 0.10 | 0.13 | ||
IV | 0.00 | 0.05 | 0.02 | 0.03 | ||
ER/HER2 status | 0.546 | 0.458 | ||||
ER+/HER2- | 0.50 | 0.59 | 0.71 | 0.68 | ||
ER+/HER2+ | 0.17 | 0.08 | 0.09 | 0.12 | ||
ER-/HER2+ | 0.00 | 0.06 | 0.06 | 0.06 | ||
ER-/HER2- | 0.33 | 0.27 | 0.14 | 0.14 | ||
Grade | 0.795 | 0.340 | ||||
Low | 0.18 | 0.20 | 0.35 | 0.28 | ||
Intermediate | 0.27 | 0.36 | 0.35 | 0.41 | ||
High | 0.55 | 0.44 | 0.30 | 0.31 | ||
Tumor size | 0.792 | 0.367 | ||||
T1 | 0.64 | 0.64 | 0.73 | 0.68 | ||
T2 | 0.36 | 0.32 | 0.20 | 0.26 | ||
T3 | 0.00 | 0.04 | 0.07 | 0.06 | ||
Lymph node status | 0.576 | 0.550 | ||||
Positive | 0.18 | 0.26 | 0.26 | 0.29 | ||
Negative | 0.82 | 0.74 | 0.74 | 0.71 | ||
Statusa | 0.485 | 0.091 | ||||
DOC | 0.08 | 0.02 | 0.02 | 0.04 | ||
DOD | 0.08 | 0.06 | 0.07 | 0.05 | ||
AWD | 0.00 | 0.03 | 0.04 | 0.01 | ||
NED | 0.84 | 0.89 | 0.87 | 0.9 |